Skip to main content
RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.57
-0.12 (-1.56%)
At close: Mar 9, 2026, 4:00 PM EDT
7.57
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:20 PM EDT

RxSight Revenue

In the year 2025, RxSight had annual revenue of $134.48M, down -3.89%. RxSight had revenue of $32.61M in the quarter ending December 31, 2025, a decrease of -18.91%.

Revenue (ttm)
$134.48M
Revenue Growth
-3.89%
P/S Ratio
2.31
Revenue / Employee
$291,711
Employees
461
Market Cap
311.77M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025134.48M-5.45M-3.89%
Dec 31, 2024139.93M50.85M57.09%
Dec 31, 202389.08M40.07M81.77%
Dec 31, 202249.01M26.41M116.90%
Dec 31, 202122.59M7.92M53.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Dec 31, 2004 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Viemed Healthcare 270.28M
Cerus 206.13M
Pacific Biosciences of California 160.01M
Quanterix 138.90M
Standard BioTools 85.33M
Delcath Systems 85.23M
908 Devices 56.20M
TriSalus Life Sciences 45.15M
Revenue Rankings

RXST News

More News